Suchergebnisse - "Rahman, Omar"

PubPharm (10)

1

Health-related quality of life in cancer patients treated with PD-(L)1 inhibitors : a systematic review

enthalten in: Expert review of anticancer therapy | 2018

von Abdel-Rahman, O. | Oweira, H. | Giryes, A.

2

Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2017

von Lasheen, S. | Shohdy, K. | Kassem, L. | +1

3

Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors : a systematic review

enthalten in: Expert review of anticancer therapy | 2017

von Abdel-Rahman, O. | Oweira, H. | Petrausch, U. | +6

4

Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors : a systematic review

enthalten in: Expert review of anticancer therapy | 24 Feb 2017

von Abdel-Rahman, O. | Oweira, H. | Schmidt, J. | +1

5

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

6

Second line systemic therapy options for advanced hepatocellular carcinoma; a systematic review

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

7

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus : a comparative systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

8

Risk of mucocutaneous toxicities in patients with solid tumors treated with everolimus; a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2014

von Abdel-Rahman, O. | Fouad, M.

9

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib : an updated systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2014

von Abdel-Rahman, O. | Fouad, M.

10

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2014

von Abdel-Rahman, O. | Fouad, M.

1
[1]